NO20045504L - Substituerte tiofener, fremgangsmate for fremstilling, deres anvendelse som medikament eller diagnostisk middel samt et medikament inneholdende disse - Google Patents

Substituerte tiofener, fremgangsmate for fremstilling, deres anvendelse som medikament eller diagnostisk middel samt et medikament inneholdende disse

Info

Publication number: NO20045504L
Authority: NO; Norway
Prior art keywords: drug; preparation; methods; diagnostic agent; substituted thiophenes
Prior art date: 2002-06-04

Application number

NO20045504A

Other languages

English (en)

Other versions

NO329351B1 (no

Inventor

Klaus Wirth

Hans-Jochen Lang

Armin Hofmeister

Markus Bleich

Michael Gekle

Uwe Heinelt

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-04

Filing date

2004-12-16

Publication date

2005-01-25

2004-12-16 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2005-01-25 Publication of NO20045504L publication Critical patent/NO20045504L/no

2010-10-04 Publication of NO329351B1 publication Critical patent/NO329351B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)

NO20045504A 2002-06-04 2004-12-16 Substituerte tiofener, anvendelse derav samt legemiddel for human- eller veterinaermedisinsk anvendelse NO329351B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10224892A DE10224892A1 (de)	2002-06-04	2002-06-04	Substituierte Thiophene, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PCT/EP2003/005465 WO2003101984A1 (de)	2002-06-04	2003-05-26	Substituierte thiophene, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament

Publications (2)

Publication Number	Publication Date
NO20045504L true NO20045504L (no)	2005-01-25
NO329351B1 NO329351B1 (no)	2010-10-04

Family

ID=29557542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20045504A NO329351B1 (no)	2002-06-04	2004-12-16	Substituerte tiofener, anvendelse derav samt legemiddel for human- eller veterinaermedisinsk anvendelse

Country Status (32)

Country	Link
EP (1)	EP1513834B1 (no)
JP (1)	JP4511924B2 (no)
KR (1)	KR101087966B1 (no)
CN (1)	CN1324024C (no)
AR (1)	AR040239A1 (no)
AT (1)	ATE320425T1 (no)
AU (1)	AU2003273553B2 (no)
BR (1)	BR0311548A (no)
CA (1)	CA2488242C (no)
CR (1)	CR7577A (no)
DE (2)	DE10224892A1 (no)
DK (1)	DK1513834T3 (no)
EC (1)	ECSP045471A (no)
ES (1)	ES2258722T3 (no)
HR (1)	HRP20041153A2 (no)
IL (1)	IL165519A (no)
MA (1)	MA27204A1 (no)
ME (1)	MEP27608A (no)
MX (1)	MXPA04011986A (no)
MY (1)	MY129832A (no)
NO (1)	NO329351B1 (no)
OA (1)	OA12827A (no)
PE (1)	PE20040534A1 (no)
PL (1)	PL372589A1 (no)
PT (1)	PT1513834E (no)
RS (1)	RS51141B (no)
RU (1)	RU2315766C2 (no)
TN (1)	TNSN04240A1 (no)
TW (1)	TWI283675B (no)
UA (1)	UA77551C2 (no)
WO (1)	WO2003101984A1 (no)
ZA (1)	ZA200409095B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040242560A1 (en)	2003-05-22	2004-12-02	Aventis Pharma Deutschland Gmbh	Process for synthesizing heterocyclic compounds
DE10323701A1 (de)	2003-05-22	2004-12-23	Aventis Pharma Deutschland Gmbh	Verfahren zur Synthese heterocyclischer Verbindungen
US7632970B2 (en)	2003-06-30	2009-12-15	Sumitomo Chemical Company, Limited	Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
US20100056515A1 (en) *	2006-10-25	2010-03-04	Kazuyoshi Aso	Benzimidazole compounds
AU2009289846B2 (en)	2008-09-02	2014-10-16	Sanofi-Aventis	Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
RU2373929C1 (ru) *	2008-11-11	2009-11-27	Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА)	Корректор системы гемостаза, проявляющий ингибирующее действие на адгезивно-агрегационную функцию тромбоцитов для профилактики патологического тромбообразования
CN102712601A (zh) *	2009-11-12	2012-10-03	赛尔维他股份公司	化合物、其制备方法、药物组合物、化合物的用途、用于调节或调控丝氨酸/苏氨酸激酶的方法以及丝氨酸/苏氨酸激酶调节剂
RU2518740C1 (ru) *	2013-03-22	2014-06-10	Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ"	СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ДИГИДРОХЛОРИД 2-(3,4-МЕТИЛЕНДИОКСИФЕНИЛ)-9-МОРФОЛИНОЭТИЛИМИДАЗО[1,2-a]БЕНЗИМИДАЗОЛА
KR102386666B1 (ko)	2014-07-25	2022-04-15	다이쇼 세이야꾸 가부시끼가이샤	헤테로아릴로 치환된 페닐테트라히드로이소퀴놀린 화합물
KR102840252B1 (ko) *	2023-04-27	2025-07-30	한국화학연구원	시아노벤즈이미다졸 유도체, 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물
CN120112529B (zh) *	2023-09-28	2026-01-06	四川大学华西医院	一种含吡啶的化合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE754820R (fr) *	1969-08-13	1971-02-15	Schering Ag	Nouveaux derives de pyrimidine, leurs procedes de preparation et leurs
BR6915362D0 (pt) *	1969-08-16	1973-01-04	Hoechst Ag	Processo para a preparacao de 2(tienil-3-amino)1,3-diazacicloalquenos
DE2830279A1 (de) *	1978-07-10	1980-01-31	Boehringer Sohn Ingelheim	2-eckige klammer auf n-(2'-chlor-4'- methyl-thienyl-3')-n-(cyclopropylmethyl)- amino eckige klammer zu-imidazolin-(2), dessen saeureadditionssalze, dieses enthaltende arzneimittel und verfahren zu seiner herstellung
US5395847A (en) *	1993-12-02	1995-03-07	Smithkline Beecham Corporation	Imidazolyl-alkenoic acids
EP1100506A4 (en) *	1998-07-29	2002-06-26	Merck & Co Inc	INTEGRIN RECEPTOR ANTAGONISTS
DE19921883A1 (de) *	1999-05-12	2000-11-16	Bayer Ag	Substituierte Thienocycloalk(en)ylamino-1,3,5-triazine
DE19960204A1 (de) *	1999-12-14	2001-06-28	Aventis Pharma Gmbh	Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EA007987B1 (ru) *	2002-03-29	2007-02-27	Чирон Корпорейшн	Замещённые бензазолы и их применение в качестве ингибиторов киназы raf

2002
- 2002-06-04 DE DE10224892A patent/DE10224892A1/de not_active Withdrawn
2003
- 2003-05-26 AU AU2003273553A patent/AU2003273553B2/en not_active Ceased
- 2003-05-26 CN CNB038128462A patent/CN1324024C/zh not_active Expired - Fee Related
- 2003-05-26 MX MXPA04011986A patent/MXPA04011986A/es active IP Right Grant
- 2003-05-26 JP JP2004509675A patent/JP4511924B2/ja not_active Expired - Fee Related
- 2003-05-26 RU RU2004138812/04A patent/RU2315766C2/ru not_active IP Right Cessation
- 2003-05-26 PT PT03740148T patent/PT1513834E/pt unknown
- 2003-05-26 ES ES03740148T patent/ES2258722T3/es not_active Expired - Lifetime
- 2003-05-26 AT AT03740148T patent/ATE320425T1/de active
- 2003-05-26 PL PL03372589A patent/PL372589A1/xx not_active Application Discontinuation
- 2003-05-26 ME MEP-276/08A patent/MEP27608A/xx unknown
- 2003-05-26 KR KR1020047019725A patent/KR101087966B1/ko not_active Expired - Fee Related
- 2003-05-26 DE DE50302673T patent/DE50302673D1/de not_active Expired - Lifetime
- 2003-05-26 BR BR0311548-8A patent/BR0311548A/pt not_active IP Right Cessation
- 2003-05-26 OA OA1200400321A patent/OA12827A/en unknown
- 2003-05-26 CA CA2488242A patent/CA2488242C/en not_active Expired - Fee Related
- 2003-05-26 RS YUP-1038/04A patent/RS51141B/sr unknown
- 2003-05-26 UA UA20041211000A patent/UA77551C2/uk unknown
- 2003-05-26 DK DK03740148T patent/DK1513834T3/da active
- 2003-05-26 EP EP03740148A patent/EP1513834B1/de not_active Expired - Lifetime
- 2003-05-26 HR HR20041153A patent/HRP20041153A2/xx not_active Application Discontinuation
- 2003-05-26 WO PCT/EP2003/005465 patent/WO2003101984A1/de not_active Ceased
- 2003-05-30 PE PE2003000531A patent/PE20040534A1/es not_active Application Discontinuation
- 2003-06-02 TW TW092114860A patent/TWI283675B/zh not_active IP Right Cessation
- 2003-06-02 AR ARP030101958A patent/AR040239A1/es active IP Right Grant
- 2003-06-03 MY MYPI20032052A patent/MY129832A/en unknown
2004
- 2004-11-10 ZA ZA200409095A patent/ZA200409095B/xx unknown
- 2004-11-16 MA MA27952A patent/MA27204A1/fr unknown
- 2004-11-19 CR CR7577A patent/CR7577A/es unknown
- 2004-12-02 EC EC2004005471A patent/ECSP045471A/es unknown
- 2004-12-02 IL IL165519A patent/IL165519A/en not_active IP Right Cessation
- 2004-12-03 TN TNP2004000240A patent/TNSN04240A1/en unknown
- 2004-12-16 NO NO20045504A patent/NO329351B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
PE20040534A1 (es)	2004-10-25
DE10224892A1 (de)	2003-12-18
HRP20041153A2 (en)	2005-06-30
WO2003101984A1 (de)	2003-12-11
PT1513834E (pt)	2006-06-30
RU2315766C2 (ru)	2008-01-27
KR101087966B1 (ko)	2011-12-01
DE50302673D1 (de)	2006-05-11
CN1659163A (zh)	2005-08-24
TW200406409A (en)	2004-05-01
RU2004138812A (ru)	2005-07-20
HK1076460A1 (en)	2006-01-20
RS51141B (sr)	2010-10-31
CA2488242C (en)	2011-08-02
ATE320425T1 (de)	2006-04-15
TNSN04240A1 (en)	2007-03-12
JP2005533038A (ja)	2005-11-04
AU2003273553A1 (en)	2003-12-19
TWI283675B (en)	2007-07-11
MXPA04011986A (es)	2005-03-07
ECSP045471A (es)	2005-01-28
PL372589A1 (en)	2005-07-25
AR040239A1 (es)	2005-03-23
EP1513834B1 (de)	2006-03-15
RS103804A (sr)	2006-12-15
UA77551C2 (en)	2006-12-15
OA12827A (en)	2006-07-11
IL165519A (en)	2010-05-31
AU2003273553B2 (en)	2008-12-04
KR20050005532A (ko)	2005-01-13
ES2258722T3 (es)	2006-09-01
EP1513834A1 (de)	2005-03-16
JP4511924B2 (ja)	2010-07-28
NO329351B1 (no)	2010-10-04
IL165519A0 (en)	2006-01-15
CR7577A (es)	2005-06-16
MEP27608A (en)	2010-06-10
DK1513834T3 (da)	2006-07-17
MA27204A1 (fr)	2005-01-03
CN1324024C (zh)	2007-07-04
MY129832A (en)	2007-05-31
BR0311548A (pt)	2005-04-12
CA2488242A1 (en)	2003-12-11
ZA200409095B (en)	2005-05-10

Publication	Publication Date	Title
NO20032735L (no)	2003-08-06	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NO20032733D0 (no)	2003-06-16	Difenyl azetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
DK1730131T3 (da)	2012-08-13	Glucopyranosyl-substituerede benzol-derivater, lægemiddel indeholdende disse forbindelser, deres anvendelse og fremgangsmåder til deres fremstilling
NO20052496D0 (no)	2005-05-24	Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
DK1673352T3 (da)	2009-07-06	Sulfoximinsubstituerede pyrimidiner som CDK- og/eller VEGF-inhibitorer, deres fremstilling og anvendelse som lægemiddel
DK1572707T3 (da)	2006-08-14	Hidtil ukendte aromatiske fluorglycosidderivater, lægemidler indeholdende disse forbindelser og anvendelse heraf
BRPI0312649A2 (pt)	2017-05-16	compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
DK1781656T3 (da)	2008-05-05	Arylsucbstituerede polycykliske aminer, fremgangsmåde til fremstilling heraf samt anvendelse heraf som lægemiddel
BRPI0607762B8 (pt)	2021-05-25	análogos de glp-1, composição farmacêutica contendo os mesmos e uso de um composto
DK1562946T3 (da)	2010-09-20	Nye xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel
DK1732917T3 (da)	2009-11-30	Udvalgte CGRP-antagonister, fremgangsmåde til fremstilling deraf, samt anvendelse deraf som lægemiddel
NO20042478L (no)	2004-08-12	Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter
NO20030870D0 (no)	2003-02-25	Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelseog fremgansgmåte for fremstilling derav
NO20040356L (no)	2004-03-19	Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
NO20044615L (no)	2004-10-26	Tropanderivater som CCR5-modulatorer
NO20044322L (no)	2004-10-12	Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
NO20045504L (no)	2005-01-25	Substituerte tiofener, fremgangsmate for fremstilling, deres anvendelse som medikament eller diagnostisk middel samt et medikament inneholdende disse
DK1831240T3 (da)	2009-11-23	18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse
NO20054876D0 (no)	2005-10-21	Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
PT1560826E (pt)	2006-07-31	Compostos piridopirimidinona, seus processos de preparacao e composicoes farmaceuticas que os contem
BRPI0312413A2 (pt)	2016-08-02	compostos, composições farmacêuticas contendo os mesmos, e método de utilização para os mesmos
NO20035602D0 (no)	2003-12-16	Sammensetning som omfatter en PDE-4-inhibitor og H1- reseptorantagonist, samt anvendelse derav til fremstilling av et medikament forbehandling av åndedrettsykdommer
NO20022801D0 (no)	2002-06-12	Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse
DK1509498T3 (da)	2007-02-26	Pentafloursulfanyl-benzoylguanidiner, fremgangsmåder til fremstilling deraf, anvendelse deraf som medikament eller diagnostikum samt medikament indeholdende dem
DK1773796T3 (da)	2010-06-21	Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf

Legal Events

Date	Code	Title	Description
2018-12-27	MM1K	Lapsed by not paying the annual fees